ZBTB17 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5103320-Each-of-1 | In Stock | ₹ 46,502.50 |
PIPA5103320 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,502.50
GST (18%): ₹ 8,370.45
Total Price: ₹ 54,872.95
Antigen
ZBTB17
Classification
Polyclonal
Conjugate
Unconjugated
Gene
ZBTB17
Gene Alias
AA589413; LP-1; Miz1; Miz-1; Myc-interacting zinc finger protein 1; Myc-interacting Zn finger protein-1; mZ13; pHZ-67; Polyomavirus late initiator promoter-binding protein; ZBTB17; Zfp100; Zfp-100; zinc finger and BTB domain containing 17; zinc finger and BTB domain-containing protein 17; Zinc finger protein 100; zinc finger protein 151; zinc finger protein 151 (pHZ-67); zinc finger protein 60; Zinc finger protein Z13; ZNF151; ZNF60
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
22642, 313666, 7709
Content And Storage
-20°C
Form
Liquid
Applications
Western Blot
Concentration
1 mg/mL
Formulation
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.
Q13105, Q60821
Gene Symbols
ZBTB17
Immunogen
A synthesized peptide derived from human ZBTB17(Accession Q13105), corresponding to amino acid residues V195-A245.
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human, Mouse, Rat
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Antibody detects endogenous levels of total ZBTB17
- Transcription factor that can function as an activator or repressor depending on its binding partners, and by targeting negative regulators of cell cycle progression
- Plays a critical role in early lymphocyte development, where it is essential to prevent apoptosis in lymphoid precursors, allowing them to survive in response to IL7 and undergo proper lineage commitment
- Has been shown to bind to the promoters of adenovirus major late protein and cyclin D1 and activate transcription
- Required for early embryonic development during gastrulation.